Clinical Decision Support System Market, Global, 2024-2030

AI Integration is Driving Transformational Growth by Enabling Improvements in Clinical Outcomes

The increasing focus on effective population health management is prompting healthcare organizations to adopt next-generation clinical decision support tools that drive market growth. Healthcare systems continue to face significant clinical quality and efficiency challenges, leading to a heightened focus on implementing clinical decision support systems (CDSS). These tools facilitate early diagnosis and timely, precise clinical interventions in both hospital and home-based healthcare settings. They also help prevent complications in patient conditions, thereby reducing the need for costly interventions such as hospital readmissions and ICU admissions. Technological advancements in artificial intelligence (AI) and machine learning, including generative AI and conversational AI, are boosting ongoing innovation in CDSS solutions.

This Frost & Sullivan report provides an overview of the global CDSS market, offering a detailed analysis, including a revenue forecast, for each application segment, namely, decision evidence/protocols, decision workflow, decision analytics, and decision delivery. The report also examines the factors driving and restraining this market and identifies the opportunities emerging from the changes in this space for market players and stakeholders to leverage. The base year is 2024, and the forecast period is from 2025 to 2030.

Revenue Forecast

The revenue estimate for the base year 2024 is $10,752.8 million, with a CAGR of 7.6% for the study period from 2024 to 2030.

Scope of Analysis

• Clinical decision support (CDS) provides clinicians and healthcare staff with knowledge and person-specific information that helps them improve clinical decisions and enhance patient healthcare.
• A clinical decision support system (CDSS) is a broad concept with many definitions that are used variably. It encompasses a variety of tools to enhance decision-making in the clinical workflow.
• CDSS includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that consist of the electronic health record (EHR) and are maintained by an IT platform.
• This report delivers a detailed analysis of the CDSS market and its applications, specifically, decision evidence/protocols, decision workflow, decision analytics, and decision delivery.
• The report analyzes industry challenges, drivers, and restraints, and offers a revenue forecast for each application area.
• It covers important business models, the regulatory outlook, cost structures, and the competitive landscape.
• Description of the top growth opportunities for the global CDSS market in the context of user relevance and calls to action has also been provided.
• The revenue estimates in this study focus only on revenue attributed to CDSS. In some cases, such as analytics, electronic health records, and device companies, CDSS revenue represents a small part of a larger revenue stream.

The Impact of the Top 3 Strategic Imperatives on the CDSS Industry

Disruptive Technologies

WHY: The CDSS has witnessed significant advancements with the development and integration of new technologies such as AI, cloud, predictive analytics, and mobile platforms, and it will continue to impact CDSS workflows in the next few years. To achieve a highly accessible, flexible, and scalable CDSS solution, end users will continue to look for technology advancements.

FROST PERSPECTIVE: Companies need to identify new use cases and build a strong foundation of evidence-based content. The integration of dynamic AI, specifically, a combination of conversational AI and generative AI (GenAI), can empower end users with easy access to relevant information, enabling them to, for instance, create documents for administrative purposes.

Innovative Business Models

WHY: A high upfront installation and implementation cost has restrained the widespread adoption of CDSS solutions. CDSS has significant potential to improve healthcare outcomes with better clinical recommendations, ultimately benefiting patients and providers in terms of cost and resource utilization.

FROST PERSPECTIVE: Evolving business models such as software-as-a-service (SaaS), subscription models, and risk-based incentives created by technology vendors can provide flexibility in upfront investment and boost CDSS adoption. Growing awareness about the long-term benefits of improved health outcomes and economic growth will drive CDSS growth in the next few years.

Transformative Megatrends

WHY: Medical errors and staff burnout affect healthcare systems' ability to provide optimal patient care. Transitions to home care, a focus on value-based care, an increasing number of data sources, revisions of guidelines, and revenue losses also present significant challenges. Moreover, growing healthcare consumerism and a shift towards personalized care exhaust stakeholders in the face of critical decision-making moments. This is where CDSS has the biggest impact.

FROST PERSPECTIVE: This evolving market demands that vendors regularly update their products and features. Expanding offerings is critical to remaining a viable player. However, such developments cannot happen in isolation. Vendors need to include key end users and decision-makers in their research and development (R&D) programs to best target their investments toward those stakeholders' pain points. To stay ahead of the competition, companies must utilize both organic and inorganic growth pathways.

Key Competitors

• Optum
• EBSCO
• Elsevier
• Hearst Health
• Merative
• Medicomp Systems
• Wolters Kluwer
• RethinkFirst
• Glass Health
• UNORK
• Premier Inc. (STANTON HEALTH)
• Getinge
• Motive Medical Intelligence
• athenahealth
• EvidenceCare
• HCA Healthcare
• MEDITECH
• eClinicalWorks
• Wolters Kluwer
• RIMIDI
• Inovalon
• Vizio
• Flatiron Health (Roche)
• Medecision
• MCG Health
• Epic
• Medical Informatics Corp.
• Medtronic
• Oracle Health
• Philips Healthcare
• GE Healthcare
• Stat Pearls

Competitive Environment

Number of Competitors

>50 with revenue greater than $1.0 million

Competitive Factors

Cost, performance, support, technology, reliability, contractor relationships

Key End-user Industry Verticals

Providers, hospitals, primary care centers, medical devices, payers

Leading Competitors

Wolters Kluwer, Philips Healthcare, Optum, Hearst Health, Oracle Health

Revenue Share of Top 4 Competitors (2024)

18.3%

Other Notable Competitors

athenahealth, Elsevier, EBSCO, eClinicalWorks, Epic

Distribution Structure

OEMs, retail sales, direct sales, Cloud-based SaaS

Notable Acquisitions and Mergers

Health Catalyst acquired ARMUS Corporation; Oracle acquired Cerner

Growth Drivers

Value-based Care and Population Health Management: The shift towards value-based care models and population health management strategies has placed a greater emphasis on CDSS. These solutions can assist healthcare providers in identifying high-risk patients, stratifying populations, and developing targeted interventions. By supporting evidence-based decision-making, CDSS contribute to improved patient outcomes and better management of chronic conditions, aligning with the goals of value-based care.

Growing Demand for Personalized Medicine: Personalized medicine, which involves tailoring medical treatment to individual patients based on their unique characteristics, is gaining traction. CDSS can play a crucial role in facilitating personalized medicine by integrating patient-specific data, genetic information, and clinical guidelines to provide tailored recommendations. This growing demand for personalized medicine is a significant driver.

Rising Healthcare Costs and Resource Constraints: Healthcare systems worldwide are facing increasing financial pressures and resource constraints. CDSS can help optimize resource utilization by providing real-time clinical insights, reducing unnecessary tests and procedures, and improving overall efficiency. This cost-effectiveness aspect is a significant driver for the adoption of CDSS solutions.

Growth Restraints

Cost and Budgetary Constraints: Implementing and maintaining CDSS software can be costly, especially for smaller healthcare organizations or those with limited budgets. The investments in hardware, software licenses, infrastructure upgrades, and ongoing maintenance and support costs can be significant. Budgetary constraints may deter healthcare providers from adopting CDSS, especially if they perceive the benefits as uncertain or difficult to quantify.

Clinician Acceptance and Alert Fatigue: Clinicians may be skeptical of automated systems' accuracy or be concerned about a loss of autonomy. Moreover, too many or unimportant alerts may lead to alert fatigue among physicians, affecting the usage of CDSS.

System Integration Complexities: Variations in standards for healthcare records can present challenges in effective CDSS integration with existing hospital IT systems.